Search
Dipropylene glycol
go.drugbank.com/drugs/DB14140InvestigationalProducts: Abelia pomegranate bounce up maskCephalexin
go.drugbank.com/drugs/DB00567ApprovedInvestigationalVet approved[A179071] Cephalexin is used to treat a number of susceptible bacterial infections through inhibition of cell wall synthesis.[A179083,L6547] Cephalexin was approved by the FDA on 4 January 1971.
Products: Nu-cephalex Tab 500mg, Nu-cephalex Tab 250mgMyeloproliferative Disorders
go.drugbank.com/conditions/DBCOND0029888Synonyms: Myeloproliferative disease, no ICD-O subtype, Chronic myeloproliferative disease, no ICD-O subtypePeripheral T-Cell Lymphoma (PTCL)
go.drugbank.com/conditions/DBCOND0079798Drugs: Brentuximab vedotinSynonyms: Peripheral T-cell lymphoma, no ICD-O subtype, Peripheral T-cell lymphoma, no International Classification of Diseases for Oncology subtypeSumatriptan
go.drugbank.com/drugs/DB00669ApprovedInvestigational[A179761] Sumatriptan was granted FDA approval on 28 December 1992.[L6805] … Sumatriptan is a serotonin receptor agonist commonly used to treat migraines and sometimes cluster headaches.
Synonyms: (3-[2-(dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide, 3-[2-(dimethylamino)ethyl]-N-methylindole-5-methanesulfonamideCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeDapagliflozin
go.drugbank.com/drugs/DB06292ApprovedInvestigational[A261601] Dapagliflozin was originally approved by the FDA on Jan 08, 2014, to improve glycemic control in adults with type 2 diabetes in conjunction with diet and exercise. … [A261596] When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose reabsorption in the proximal tubule of the nephron and causing glycosuria
Products: Nb-dapagliflozinTriamcinolone
go.drugbank.com/drugs/DB00620ApprovedInvestigationalVet approvedTriamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. … [L8246,L8249,L8252,L8255,L8258,L8261,L8264] Triamcinolone was granted FDA approval on 3 December 1957.
Mixtures: ReadySharp-KCategories: Agents to Treat Airway Disease